Amgen Inc

F:AMG

Amgen is a biotechnology company that discovers, develops, manufactures, and sells prescription medicines for serious diseases. Its drugs focus on areas such as cancer, bone health, inflammation, heart disease, and rare conditions. The company’s main customers are doctors, hospitals, specialty pharmacies, and health systems that prescribe or dispense these treatments to patients. Amgen makes money by selling branded medicines and biologic therapies, which are large-molecule drugs made from living cells rather than traditional chemical compounds. It also earns income from medicines it co-develops with partners and from sales tied to its global distribution and commercialization network. Because many of its products are complex biologics, Amgen’s business depends on deep scientific expertise, regulatory approvals, and specialized manufacturing. What sets Amgen apart is its role as a large-scale biologics company. Instead of competing mainly on generic drugs, it focuses on hard-to-make treatments for diseases where patients often need long-term care and doctors want proven, targeted medicines. That makes Amgen an important supplier to the healthcare system and gives it a business built around science, patents, and relationships with specialist prescribers.